MCID: SKN027
MIFTS: 46

Skin Conditions

Categories: Immune diseases, Skin diseases

Aliases & Classifications for Skin Conditions

MalaCards integrated aliases for Skin Conditions:

Name: Skin Conditions 38 43
Dermatologic Disorders 73

Classifications:



External Ids:

UMLS 73 C0037274

Summaries for Skin Conditions

MedlinePlus : 43 Your skin is your body's largest organ. It covers and protects your body. Your skin Holds body fluids in, preventing dehydration Keeps harmful microbes out, preventing infections Helps you feel things like heat, cold, and pain Keeps your body temperature even Makes vitamin D when the sun shines on it Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Skin Conditions, also known as dermatologic disorders, is related to contact dermatitis and dermatitis, and has symptoms including pruritus, dry skin and enanthema. An important gene associated with Skin Conditions is CD247 (CD247 Molecule), and among its related pathways/superpathways are Toll-like Receptor Signaling Pathway and Th17 cell differentiation. The drugs mometasone furoate and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and t cells.

Related Diseases for Skin Conditions

Diseases related to Skin Conditions via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 133)
# Related Disease Score Top Affiliating Genes
1 contact dermatitis 29.8 IL1A TNF
2 dermatitis 11.0
3 seborrheic dermatitis 10.9
4 lymphomatoid papulosis 10.9
5 discoid lupus erythematosus 10.9
6 darier-white disease 10.7
7 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.7
8 erythroderma, ichthyosiform, congenital reticular 10.7
9 crouzon syndrome with acanthosis nigricans 10.7
10 nevoid hypermelanosis, linear and whorled 10.7
11 dowling-degos disease 10.7
12 scleredema 10.7
13 transient bullous dermolysis of the newborn 10.5
14 erythrokeratodermia variabilis et progressiva 1 10.5
15 melanocytic nevus syndrome, congenital 10.5
16 skin creases, congenital symmetric circumferential, 1 10.5
17 nail disorder, nonsyndromic congenital, 1 10.5
18 benign chronic pemphigus 10.5
19 pityriasis rubra pilaris 10.5
20 porokeratosis 1, multiple types 10.5
21 vitiligo-associated multiple autoimmune disease susceptibility 6 10.5
22 rothmund-thomson syndrome 10.5
23 restrictive dermopathy, lethal 10.5
24 wiskott-aldrich syndrome 10.5
25 ichthyosis, x-linked 10.5
26 vitiligo-associated multiple autoimmune disease susceptibility 1 10.5
27 neutrophilic dermatosis, acute febrile 10.5
28 psoriasis 14, pustular 10.5
29 achondroplasia, severe, with developmental delay and acanthosis nigricans 10.5
30 granuloma annulare 10.5
31 erythema multiforme 10.5
32 acquired generalized lipodystrophy 10.5
33 junctional epidermolysis bullosa 10.5
34 palmoplantar keratosis 10.5
35 necrobiosis lipoidica 10.5
36 porokeratosis 10.5
37 photoallergic dermatitis 10.5
38 achenbach syndrome 10.5
39 inverted follicular keratosis 10.5
40 scabies 10.5
41 dermatitis herpetiformis 10.5
42 rosacea 10.5
43 pityriasis versicolor 10.5
44 aquagenic pruritus 10.5
45 erythema nodosum, idiopathic 10.5
46 gianotti crosti syndrome 10.5
47 granulomatous rosacea 10.5
48 grover's disease 10.5
49 guttate psoriasis 10.5
50 hydroa vacciniforme 10.5

Graphical network of the top 20 diseases related to Skin Conditions:



Diseases related to Skin Conditions

Symptoms & Phenotypes for Skin Conditions

UMLS symptoms related to Skin Conditions:


pruritus, dry skin, enanthema, exanthema, skin manifestations, nasal itching

Drugs & Therapeutics for Skin Conditions

Drugs for Skin Conditions (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1369)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
mometasone furoate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83919-23-7
2
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 104987-11-3 445643 439492
3
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
4
Acitretin Approved Phase 4,Phase 3,Phase 2,Not Applicable 55079-83-9 5284513 6437841
5
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 94-09-7, 1994-09-7 2337
6 tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
7
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
8
Petrolatum Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 8009-03-8
9
Titanium dioxide Approved Phase 4,Phase 2,Not Applicable 13463-67-7
10
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
11
Ustekinumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 815610-63-0
12
Desonide Approved, Investigational Phase 4,Phase 3,Not Applicable 638-94-8 5311066
13
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 4594 9579578
14
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 185243-69-0
15
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
16
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 6006 143
17
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-05-2, 1959-05-2 126941
18
Infliximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 170277-31-3
19
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
20
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
21
Amorolfine Approved, Investigational Phase 4,Phase 3 78613-35-1
22
Coal tar Approved Phase 4,Phase 3,Phase 1,Not Applicable 8007-45-2
23
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-21-8 3385
24
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55-56-1 2713 9552079
25
Phenol Approved, Experimental Phase 4,Not Applicable 108-95-2 996
26
Clindamycin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 18323-44-9 29029
27
Glycerol Approved, Investigational Phase 4,Phase 1,Not Applicable 56-81-5 753
28
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 124-94-7 31307
29
Mineral oil Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 8042-47-5
30
Clobetasol Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 25122-46-7, 25122-41-2 5311051 32798
31
Aminolevulinic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 106-60-5 137
32
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 69-72-7 338
33
Isotretinoin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4759-48-2 5538 5282379
34
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 60142-96-3 3446
35
Fexofenadine Approved, Investigational Phase 4,Phase 2 83799-24-0 3348
36
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-45-6, 75614-87-8 774
37
Pregabalin Approved, Illicit, Investigational Phase 4,Not Applicable 148553-50-8 5486971
38
Dapsone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 80-08-0 2955
39
Imiquimod Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99011-02-6 57469
40
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 94-36-0 7187
41
acetic acid Approved Phase 4 64-19-7 176
42
Hydroquinone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 123-31-9 785
43
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6
44
Zinc oxide Approved Phase 4,Phase 3,Phase 2,Not Applicable 1314-13-2
45
Fluticasone Approved, Experimental Phase 4,Early Phase 1,Not Applicable 90566-53-3 62924
46
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137071-32-0 6447131 17753757
47
Azelaic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 123-99-9 2266
48
Methylene blue Approved, Investigational Phase 4,Phase 3,Not Applicable 61-73-4
49
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 6055-19-2, 50-18-0 2907
50
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703

Interventional clinical trials:

(show top 50) (show all 10000)
# Name Status NCT ID Phase Drugs
1 The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site Unknown status NCT02400372 Phase 4
2 Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo Unknown status NCT01333410 Phase 4 tacrolimus ointment;Mometasone furoate
3 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Unknown status NCT02438020 Phase 4 Metformin
4 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
5 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Unknown status NCT01439425 Phase 4
6 The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction Unknown status NCT01427400 Phase 4 Botulinum Toxin-A;Saline
7 Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Unknown status NCT02495064 Phase 4 Mometasone Furoate Cream
8 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
9 Proton Pump Inhibitors Use in Patients With Psoriasis Unknown status NCT02624544 Phase 4 esomeprazole;desonide
10 Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity Unknown status NCT02602925 Phase 4
11 Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. Unknown status NCT02248792 Phase 4 Methotrexate
12 Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea Unknown status NCT03053700 Phase 4 Bromonide 0.33% gel
13 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Unknown status NCT01558310 Phase 4 Ustekinumab;Placebo
14 Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 Unknown status NCT01443338 Phase 4 Triptergium Wilfordii;Acitretin
15 Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy Unknown status NCT01237262 Phase 4 Adalimumab, etanercept, infliximab
16 An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use Unknown status NCT01132235 Phase 4
17 Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis Unknown status NCT00707070 Phase 4 efalizumab plus placebo;efalizumab plus acitretin
18 Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness Unknown status NCT00150930 Phase 4
19 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4 Amorolfine (Antifungal);RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
20 Study on the Effects of Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older Unknown status NCT01709058 Phase 4 Intramuscular/paravertebral injections of Oxygen-Ozone
21 Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation Unknown status NCT02904564 Phase 4
22 Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy Unknown status NCT01844141 Phase 4 70% alcohol;70% alcohol - 0.5% clorhexidine
23 Efficacy & Safety of Clindamycin and Tretinoin in Acne Unknown status NCT01111994 Phase 4 Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel
24 Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema Unknown status NCT02601222 Phase 4 Runzao zhiyang capsule;Runzaozhiyang capsule agent simulation;Urea cream
25 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
26 Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Unknown status NCT01491711 Phase 4 Methylaminolevulinate PDT in 2 sessions;Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
27 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
28 Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel Unknown status NCT02647151 Phase 4 METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE
29 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4 pregabalin 75mg daily for 12 weeks;fexofenadine 60 mg daily for 12 weeks;placebo
30 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Unknown status NCT01656226 Phase 4
31 Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris Unknown status NCT02944461 Phase 4 Dapsone 7.5 % gel
32 Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis Unknown status NCT01413763 Phase 4 Imiquimod cream 3.75%;Placebo cream
33 Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus Unknown status NCT01073501 Phase 4 Pregabalin;Placebo
34 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4 Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
35 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4 clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
36 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4 Benzoyl peroxide and sulfur
37 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
38 Clinical Trial of Hydroquinone Versus Miconazol in Melasma Unknown status NCT01661556 Phase 4 Miconazole;Hydroquinone
39 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
40 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
41 Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Unknown status NCT01246921 Phase 4 Fluticasone proprionate 0.05% cream
42 Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) Unknown status NCT01082393 Phase 4 topical tacrolimus treatment;topical pimecrolimus treatment;local mometasone furoate treatment;cold cream
43 Azelaic Acid Versus Hydroquinone in Melasma Unknown status NCT00927771 Phase 4 azelaic acid gel;hydroquinone cream
44 Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Unknown status NCT01229319 Phase 4 Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm;Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
45 Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia Unknown status NCT02999737 Phase 4
46 Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients Unknown status NCT02982148 Phase 4
47 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Unknown status NCT02905916 Phase 4 PEG-rhG-CSF
48 Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer Unknown status NCT02903524 Phase 4 Doxorubicin Hydrochloride Liposome injection and cyclophosphamide;pirarubicin and cyclophosphamide
49 Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer Unknown status NCT02781259 Phase 4 Indocyanine green
50 Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer Unknown status NCT02766530 Phase 4

Search NIH Clinical Center for Skin Conditions

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Skin Conditions cell therapies at LifeMap Discovery.

Genetic Tests for Skin Conditions

Anatomical Context for Skin Conditions

MalaCards organs/tissues related to Skin Conditions:

41
Skin, Bone, T Cells, Testes, Brain, Bone Marrow, Kidney

Publications for Skin Conditions

Articles related to Skin Conditions:

(show top 50) (show all 453)
# Title Authors Year
1
Correlations between skin hydration parameters and corneocyte-derived parameters to characterize skin conditions. ( 29603859 )
2018
2
An approach on the potential use of probiotics in the treatment of skin conditions: acne and atopic dermatitis. ( 29676446 )
2018
3
Improvement of skin conditions by ingestion of <i>Aspergillus kawachii</i> (Koji) extract containing 14-dehydroergosterol in a randomized, double-blind, controlled trial. ( 29563825 )
2018
4
Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions. ( 29720979 )
2018
5
Psychosocial adjustment to skin conditions resulting in visible difference (disfigurement): What do we know? Why don't we know more? How shall we move forward? ( 29872669 )
2018
6
A Randomized Controlled Trial Determining Variances in Ostomy Skin Conditions and the Economic Impact (ADVOCATE Trial). ( 29300287 )
2018
7
Assessment and management of skin conditions in older people. ( 30063391 )
2018
8
Developing sensitivity to the psychological burden associated with skin conditions: a call for training. ( 30141548 )
2018
9
Could we be doing more to provide an evidence base for rare skin conditions? ( 30141565 )
2018
10
Effect of Torula Yeast (Candida utilis)-Derived Glucosylceramide on Skin Dryness and Other Skin Conditions in Winter. ( 30175789 )
2018
11
Long-Range Diagnosis of and Support for Skin Conditions in Field Settings. ( 30274480 )
2018
12
Disentangling the Complexity of a Hexa-Herbal Chinese Medicine Used for Inflammatory Skin Conditions-Predicting the Active Components by Combining LC-MS-Based Metabolite Profiles and in vitro Pharmacology. ( 30344490 )
2018
13
Effects of Composite Supplement Containing Collagen Peptide and Ornithine on Skin Conditions and Plasma IGF-1 Levels-A Randomized, Double-Blind, Placebo-Controlled Trial. ( 30513923 )
2018
14
Self-management of chronic skin conditions. ( 30521388 )
2018
15
Amelioration of atopic-like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts. ( 28815692 )
2017
16
Millimeter-wave emissivity as a metric for the non-contact diagnosis of human skin conditions. ( 28836682 )
2017
17
Application of three hygrometers under different skin conditions in dogs: dry, moist and haired skin. ( 28868812 )
2017
18
Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions. ( 28676883 )
2017
19
Common Skin Conditions in Children: Congenital Melanocytic Nevi and Infantile Hemangiomas. ( 28196319 )
2017
20
The impact of skin conditions on generic health-related quality of life. ( 28504391 )
2017
21
Nutritional Status and Habitual Dietary Intake Are Associated with Frail Skin Conditions in Community-Dwelling Older People. ( 28112767 )
2017
22
Context for Practice: Clinical Challenges Related to Rare and Uncommon Skin Conditions. ( 28682852 )
2017
23
Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness. ( 28869774 )
2017
24
Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study. ( 29132305 )
2017
25
The Potential Psychological Impact of Skin Conditions. ( 28150109 )
2017
26
Common Skin Conditions in Children: Skin Infections. ( 28196318 )
2017
27
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817452 )
2017
28
Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients. ( 29273489 )
2017
29
Dry skin conditions are related to the recovery rate of skin temperature after cold stress rather than to blood flow. ( 27917468 )
2017
30
Effects of intake of Lactobacillus casei subsp. casei 327 on skin conditions: a randomized, double-blind, placebo-controlled, parallel-group study in women. ( 28748132 )
2017
31
Patient-centred health care for people with chronic skin conditions. ( 28833008 )
2017
32
The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals. ( 28133874 )
2017
33
Common Skin Conditions in Children: Noninfectious Rashes. ( 28196317 )
2017
34
Common Skin Conditions in Children: Neonatal Skin Lesions. ( 28196316 )
2017
35
No-rinse mousse shampoos for skin conditions in dogs and cats. ( 28694380 )
2017
36
The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions. ( 29274241 )
2017
37
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817454 )
2017
38
Common Skin Conditions in Children: Foreword. ( 28196315 )
2017
39
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. ( 28063031 )
2017
40
Drugs to treat dermatologic disorders. ( 28445345 )
2017
41
Obstructive sleep apnea and dermatologic disorders. ( 28511831 )
2017
42
Oral Complications of Dermatologic Disorders. ( 28778310 )
2017
43
Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged. ( 27544020 )
2016
44
Parental, child, and adolescent experience of chronic skin conditions: A meta-ethnography and review of the qualitative literature. ( 27768987 )
2016
45
Inflammatory Skin Conditions Associated With Radiotherapy. ( 28010872 )
2016
46
Is education enough to improve quality of life in people with chronic inflammatory skin conditions? ( 27317274 )
2016
47
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. ( 26994263 )
2016
48
Skin conditions in a South African tuberculosis hospital: Prevalence, description, and possible associations. ( 27419379 )
2016
49
Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial. ( 26581682 )
2016
50
Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review. ( 27367679 )
2016

Variations for Skin Conditions

Expression for Skin Conditions

Search GEO for disease gene expression data for Skin Conditions.

Pathways for Skin Conditions

GO Terms for Skin Conditions

Cellular components related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 IFNK IGFL1 IGFL2 IGFL3 IL1A TNF
2 extracellular region GO:0005576 9.17 DCD IFNK IGFL1 IGFL2 IGFL3 IL1A

Biological processes related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.43 IFNK IL1A TNF
2 humoral immune response GO:0006959 9.32 IFNK TNF
3 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.16 IL1A TNF
4 positive regulation of cytokine secretion GO:0050715 8.96 IL1A TNF
5 positive regulation of protein localization to cell surface GO:2000010 8.62 CD247 TNF

Molecular functions related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNK IL1A TNF

Sources for Skin Conditions

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....